Company news

Prescient Therapeutics Limited news in 2024

Prescient Therapeutics Limited's news releases, calls and decks from 2024, newest first.

View company

US FDA allows PTX-100 Ph2 trial

December 22, 2024

Appointment of Chief Executive Officer

December 17, 2024

September 2024 Quarterly Update and Appendix 4C

October 30, 2024

Prescient CEO to step down in early 2025

September 11, 2024

Appendix 4E and 2024 Annual Report

August 26, 2024

June 2024 Quarterly Update and Appendix 4C

July 31, 2024

March 2024 Quarterly Update and Appendix 4C

April 30, 2024

December 2023 Quarterly Update and Appendix 4C

January 31, 2024

Decks in 2024